Literature DB >> 10478948

Kinetics of brain cholinesterase inhibition following metrifonate administration.

S Dachir1, B H Schmidt, A Levy.   

Abstract

In previous metrifonate (MTF) studies, there has been evidence for a preferential functional effect of the drug in cortical but not in striatal regions. In the present study we investigated the kinetics of brain cholinesterase (ChE) inhibition following an acute administration of MTF (100 mg/kg) in various brain regions of young and old Fischer 344 rats. The main objective was to test the hypothesis that the functional regional selectivity, observed in previous studies, was correlated with the extent of ChE inhibition. Using Karnovsky's method for histochemical staining, the highest staining intensity in control rats was found in the striatum and hippocampus, compared to a low basal activity in the frontal and frontoparietal cortices. In the striatum of drug treated old rats, enzyme inhibition was somewhat greater than that found in young rats. However, in the hippocampus, four to eight hours following MTF administration, the inhibition was greater in young compared to old rats. The differences in the sensitivity of various brain regions towards MTF induced ChE inhibition could not be correlated with the regional variation of MTF functional effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10478948     DOI: 10.1023/a:1021069129555

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  12 in total

1.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES.

Authors:  M J KARNOVSKY; L ROOTS
Journal:  J Histochem Cytochem       Date:  1964-03       Impact factor: 2.479

2.  Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.

Authors:  C Scali; M G Giovannini; L Bartolini; C Prosperi; V Hinz; B Schmidt; G Pepeu
Journal:  Eur J Pharmacol       Date:  1997-05-01       Impact factor: 4.432

3.  Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.

Authors:  J L Cummings; P A Cyrus; F Bieber; J Mas; J Orazem; B Gulanski
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

4.  Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Authors:  J C Morris; P A Cyrus; J Orazem; J Mas; F Bieber; B B Ruzicka; B Gulanski
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

5.  Effects of metrifonate on escape and avoidance learning in young and aged rats.

Authors:  F.J. van Der Staay; V.C. Hinz; B.H. Schmidt
Journal:  Behav Pharmacol       Date:  1996-01       Impact factor: 2.293

6.  Effects of metrifonate on impairment of learning and dysfunction of cholinergic neuronal system in basal forebrain-lesioned rats.

Authors:  A Itoh; A Nitta; M Hirose; T Hasegawa; T Nabeshima
Journal:  Behav Brain Res       Date:  1997-02       Impact factor: 3.332

7.  Effects of metrifonate on radial arm maze acquisition in middle-aged rats.

Authors:  S Dachir; B Schmidt; A Levy
Journal:  Brain Res       Date:  1997-11-28       Impact factor: 3.252

8.  Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.

Authors:  M A Kronforst-Collins; P L Moriearty; M Ralph; R E Becker; B Schmidt; L T Thompson; J F Disterhoft
Journal:  Pharmacol Biochem Behav       Date:  1997-01       Impact factor: 3.533

9.  Metrifonate effects on acetylcholine and biogenic amines in rat cortex.

Authors:  F Mori; G Cuadra; E Giacobini
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

10.  Transformation and action of metrifonate.

Authors:  I Nordgren; M Bergström; B Holmstedt; M Sandoz
Journal:  Arch Toxicol       Date:  1978-10-13       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.